[Hyperbaric oxygenation in myocardial infarct] | Canada Hyperbarics Skip to main content
Study Anesteziol Reanimatol 1994

[Hyperbaric oxygenation in myocardial infarct]

Gonchar D — Anesteziol Reanimatol, 1994

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers studied 52 patients who had experienced a heart attack, treating them with hyperbaric oxygen therapy (HBOT) sessions lasting 40-62 minutes at pressures between 0.3 and 1.1 atmospheres.

What They Found

By sessions 4-5, HBOT helped eliminate breathing issues like hypercapnia and hypoxia, normalized blood flow and respiratory functions, and improved immunity. The study found that HBOT shortened patients' stay in an intensive care unit by 1.6 days and decreased the death rate by 9.5%.

What This Means for Canadian Patients

For Canadian patients recovering from a heart attack, these findings suggest that HBOT could potentially help stabilize their condition and improve recovery. This might lead to shorter stays in intensive care and better overall outcomes for individuals.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was conducted on a small number of patients in 1994 and lacked a control group, which limits the strength of its conclusions.

Was this summary helpful?

Study Details

Study Type Study
Category Cardiac
Source Pubmed
PubMed ID 8080131
Year Published 1994
Journal Anesteziol Reanimatol
MeSH Terms Adult; Aged; Coronary Care Units; Hemodynamics; Humans; Hyperbaric Oxygenation; Length of Stay; Male; Middle Aged; Myocardial Infarction

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.